Healthcare combines pharmaceuticals, biotech, medical devices, care providers, health insurers, and health-information services. It is home to names like Eli Lilly, UnitedHealth, Johnson & Johnson, and Merck. The sector blends growth and defensive traits — demand for treatment and medicine stays relatively steady across cycles, with strong innovation catalysts in drugs and gene therapy. On this page we rank the best US healthcare stocks by the EL7 Score and compare them across value, growth, quality, safety, and capital-return factors.
5 of 11
P/E 24.4 vs period average 21.2 Richer than its history
Ranked among 267 stocks with a market cap above $2B. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/267 | ![]() | $265.58 | 30.8 | 100 | 0 | 100 | 100 |
| 2/267 | ![]() | $41.52 | 13.4 | 93 | 73 | 96 | 99 |
| 3/267 | ![]() | $121.47 | 15.1 | 83 | 80 | 96 | 99 |
| 4/267 | ![]() | $56.12 | 17.3 | 78 | 76 | 97 | 98 |
| 5/267 | ![]() | $148.18 | — | 22 | 98 | 84 | 98 |
| 6/267 | ![]() | $16.10 | 7.1 | 86 | 85 | 91 | 98 |
| 7/267 | ![]() | $32.77 | 21.1 | 83 | 96 | 94 | 98 |
| 8/267 | ![]() | $9.19 | 10.9 | 94 | 63 | 91 | 98 |
| 9/267 | ![]() | $497.11 | 17.8 | 76 | 52 | 87 | 97 |
| 10/267 | ![]() | $117.09 | 20.5 | 85 | 64 | 70 | 97 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $10B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $21B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.2% | $43B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
The white line marks the average score (64.3) · the number beside the score is the stock count
Upgrades and downgrades on the sector's stocks
The healthcare sector holds fifth place with a score of 69.53, supported by strong operational quality at 76.21 and high safety levels, despite the challenges facing valuation attractiveness at 37.65. With a median P/E ratio of 24.38, the sector displays positive momentum and sentiment, reflecting investor confidence in its financial stability against moderate growth. JNJ and QTTB stocks stand out as key leading examples that combine strong performance with qualitative standards in this sector.